Mirova Illumina, Inc. Transaction History

Mirova

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$183.43 - $232.67 $86,762 - $110,052	-473 Reduced 62.73%	281 $52,000
Q1 2023 May 12, 2023	BUY	$193.75 - $232.55 $146,087 - $175,342	754 New	754 $175,000
Q2 2022 Aug 12, 2022	BUY	$181.58 - $368.0 $175,587 - $355,856	967 New	967 $178,000
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $291,715 - $354,337	-840 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$405.61 - $524.84 $29,609 - $38,313	73 Added 9.52%	840 $340,000
Q2 2021 Aug 13, 2021	BUY	$372.84 - $481.5 $17,523 - $22,630	47 Added 6.53%	767 $362,000
Q1 2021 May 14, 2021	BUY	$361.28 - $504.76 $36,128 - $50,476	100 Added 16.13%	720 $276,000
Q4 2020 Feb 12, 2021	SELL	$292.7 - $370.96 $17,269 - $21,886	-59 Reduced 8.69%	620 $229,000
Q3 2020 Nov 12, 2020	BUY	$268.51 - $400.74 $175,605 - $262,083	654 Added 2616.0%	679 $210,000
Q4 2019 Feb 14, 2020	BUY	$288.29 - $335.49 $7,207 - $8,387	25 New	25 $8,000
Q3 2019 Nov 13, 2019	SELL	$266.84 - $378.23 $8.32 Million - $11.8 Million	-31,192 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$300.59 - $368.15 $9.37 Million - $11.5 Million	31,164 Added 111300.0%	31,192 $11.5 Million
Q4 2018 Feb 14, 2019	BUY	$272.46 - $366.54 $7,628 - $10,263	28 New	28 $8,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

Stay updated on Mirova with notifications on news.